(Q39503841)

12 September 2017

Angiogenin-mediated photosensitizer-aptamer conjugate for photodynamic therapy (English)

1 reference

12 September 2017

Xiaohai Yang

1

1 reference

12 September 2017

Jin Huang

2

1 reference

12 September 2017

Kemin Wang

3

1 reference

12 September 2017

Wei Li

4

1 reference

12 September 2017

Liang Cui

5

1 reference

12 September 2017

Xiaoping Li

6

1 reference

12 September 2017

19 July 2011

1 reference

12 September 2017

1 reference

12 September 2017

6

1 reference

12 September 2017

10

1 reference

12 September 2017

1778-1780

1 reference

The present and future role of photodynamic therapy in cancer treatment

12 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

The history of photodetection and photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

Conjugation of a photosensitizer to an oligoarginine-based cell-penetrating peptide increases the efficacy of photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

Photodynamic molecular beacon as an activatable photosensitizer based on protease-controlled singlet oxygen quenching and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

Peptide-based pharmacomodulation of a cancer-targeted optical imaging and photodynamic therapy agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

Cell specific aptamer-photosensitizer conjugates as a molecular tool in photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

Regulation of singlet oxygen generation using single-walled carbon nanotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

Aptamer-target binding triggered molecular mediation of singlet oxygen generation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

Phototoxic aptamers selectively enter and kill epithelial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

Aptamer-based tumor-targeted drug delivery for photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

Diacyllipid micelle-based nanocarrier for magnetically guided delivery of drugs in photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

New method for delivering a hydrophobic drug for photodynamic therapy using pure nanocrystal form of the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

Organically modified silica nanoparticles with covalently incorporated photosensitizer for photodynamic therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

A putative angiogenin receptor in angiogenin-responsive human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

Actin is a binding protein for angiogenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

Angiogenin is translocated to the nucleus of HeLa cells and is involved in ribosomal RNA transcription and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

Inhibition of human angiogenin by DNA aptamers: nuclear colocalization of an angiogenin-inhibitor complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

Real-time imaging of protein internalization using aptamer conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

The effect of charge on cellular uptake and phototoxicity of polylysine chlorin(e6) conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

Hypericin-mediated photodynamic therapy in combination with Avastin (bevacizumab) improves tumor response by downregulating angiogenic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

7 January 2021

The observation of angiogenin and basic fibroblast growth factor gene expression in human colonic adenocarcinomas, gastric adenocarcinomas, and hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

7 January 2021

Increased angiogenin expression in gastric cancer correlated with cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

7 January 2021

Elevated expression of angiogenin in prostate cancer and its precursors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

7 January 2021

Increased angiogenin expression in the tumor tissue and serum of urothelial carcinoma patients is related to disease progression and recurrence

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

7 January 2021

Significance of angiogenin plasma concentrations in patients with acute myeloid leukaemia and advanced myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

7 January 2021

Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

7 January 2021

Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

7 January 2021

Vascular endothelium growth factor and angiogenin in the serum of patients with osteosarcoma and Ewing's tumor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100226

7 January 2021

Identifiers

DOI

10.1002/CMDC.201100226

1 reference

12 September 2017

1 reference